Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2019
Reporting Period: Second quarter ended June 30, 2019
Context: The filing serves to announce the issuance of a press release detailing financial results for the second quarter of 2019.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes regarding financial performance or operations are detailed in the text of this filing. The document solely confirms the announcement of Q2 2019 results via an attached press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or contingencies. These items, if present, are located within the referenced press release (Exhibit 99.1), which is not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 8, 2019) for actual Q2 2019 financial figures.
- Verify the company's liquidity position and cash burn rate in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm the status of the company's common stock trading on the NASDAQ Capital Market under symbol ACHV.